Sapphire Medical

Sapphire Medical Clinics is a leading UK-based healthcare provider specializing in medical cannabis treatments for patients with chronic and complex conditions. As the first clinic of its kind to be registered by the Care Quality Commission (CQC), it provides specialist-led care across various therapeutic areas, including pain management, neurology, and psychiatry. The company is distinguished by its commitment to clinical research, utilizing its proprietary Sapphire Real-World Evidence platform and the UK Medical Cannabis Registry to monitor patient outcomes. In 2021, Sapphire Medical Clinics became part of Curaleaf International following its acquisition, allowing it to leverage global expertise in cannabinoid science. The clinic continues to play a pivotal role in expanding patient access to medical cannabis while maintaining rigorous standards of safety and efficacy.